Discover a new way to find and share stories you'll love… Learn about Reading Desk

Post Profile



Watson Said to Near $6.6 Billion Deal for Actavis

Watson Pharmaceuticals is expected to bid as much as €5 billion ($6.6 billion) for the Swiss drug maker Actavis Group, in a deal that would create one of the world's largest generic drug manufacturers.
read more

share

Generic Drug Makers in $7.5 Billion Deal

Business & Finance : DealBook (6 years ago)

Teva Pharmaceuticals Industries, the world’s largest maker of generic drugs, confirmed Friday it would buy Barr Pharmaceuticals of New Jersey for about $7.5 billion in cash and stock. Early reports of such a deal sent shares of Barr... Read Post

Watson’s Bottom Line to Get Lift From Actavis

Business & Finance : Deal Journal - WSJ.com (2 years ago)

Generic drug maker Actavis is growing faster than the European sector, according to its chief executive and is set to contribute at least €2 billion ($2.6 billion) to this year's sales of U.S. based Watson Pharmaceuticals, which bou... Read Post

Watson Said to Bid $5.9 Billion for Actavis

Business & Finance : DealBook (3 years ago)

Watson Pharmaceuticals is expected to offer 4.5 billion euros ($5.9 billion) for Swiss drug maker Actavis Group on Wednesday, in a deal that would create one of the world's largest generic drug manufacturers. Read Post


Copyright © 2011 Regator, LLC